|
Valoración de DCF de Greenwich Lifesciences, Inc. (GLSI)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Greenwich LifeSciences, Inc. (GLSI) Bundle
¡Obtenga información sobre su análisis de valoración de Greenwich Lifesciences, Inc. (GLSI) con nuestra sofisticada calculadora DCF! Precedido con datos de GLSI reales, esta plantilla de Excel le permite ajustar los pronósticos y supuestos para determinar con precisión el valor intrínseco de Greenwich Lifesciences, Inc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -3.4 | -1.9 | -4.6 | -8.0 | -9.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -3.4 | -1.9 | -4.6 | -8.0 | -9.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | .0 | 28.7 | 27.2 | 13.5 | 7.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .6 | .3 | .2 | .2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -3.4 | -1.9 | -4.6 | -7.8 | -9.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.8 | -2.2 | -4.6 | -7.8 | -9.5 | .0 | .0 | .0 | .0 | .0 |
| WACC, % | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -7 | |||||||||
| Equity Value | 7 | |||||||||
| Diluted Shares Outstanding, MM | 13 | |||||||||
| Equity Value Per Share | 0.54 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled financials for Greenwich LifeSciences, Inc. (GLSI).
- Accurate Data: Historical performance data and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC as needed.
- Instant Calculations: Quickly observe how your inputs influence the valuation of Greenwich LifeSciences, Inc. (GLSI).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Layout: Organized for simplicity and ease of navigation, complete with step-by-step guidance.
Key Features
- Comprehensive Data: Greenwich LifeSciences' historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Watch the intrinsic value of Greenwich LifeSciences (GLSI) update instantly.
- Intuitive Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
- Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based GLSI DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Greenwich LifeSciences’ intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose This Calculator for Greenwich LifeSciences, Inc. (GLSI)?
- Designed for Experts: A sophisticated tool tailored for researchers, financial analysts, and investment professionals.
- Comprehensive Data: Greenwich LifeSciences' historical and anticipated financials included for precise analysis.
- Flexible Scenario Analysis: Effortlessly model various projections and hypotheses.
- Clear Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Detailed step-by-step guidance ensures a smooth experience.
Who Should Use This Product?
- Investors: Make informed decisions with a cutting-edge valuation tool tailored for Greenwich LifeSciences, Inc. (GLSI).
- Financial Analysts: Streamline your analysis with a ready-to-customize DCF model specific to the biotech sector.
- Consultants: Efficiently modify the template for impactful client presentations or detailed reports on GLSI.
- Biotech Enthusiasts: Enhance your knowledge of valuation methodologies using practical examples from Greenwich LifeSciences, Inc. (GLSI).
- Educators and Students: Utilize it as a hands-on resource for finance and investment courses focused on the biotech industry.
What the Template Contains
- Historical Data: Includes Greenwich LifeSciences, Inc. (GLSI)’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Greenwich LifeSciences, Inc. (GLSI)’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Greenwich LifeSciences, Inc. (GLSI)’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.